HIV vaccine development: A subtype E-specific strategy

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 29, Issue 2, 1998, Pages 377-382

  Brown, Arthur E ^a   McNeil, John G ^b  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

CLASSIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; REVIEW; SOUTHEAST ASIA;

AIDS VACCINES; ASIA, SOUTHEASTERN; HIV; HIV INFECTIONS; HUMANS;

EID: 0032082284     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Artenstein AW, Coppola J, Brown AE, et al. Multiple introductions of HIV-1 subtype E into the western hemisphere. Lancet 1995; 346 : 1197-8.
2. Baxby D, Paoletti E. Potential use of non-replicating vectors as recombinant vaccines. Vaccine 1992; 10 : 8-9.
3. Brown TM, Robbins KE, Sinniah M, et al. HIV type 1 subtypes in Malaysia include B, C and E. AIDS Res Hum Retrovir 1996; 12 : 1655-7.
4. Carr JK, Salminen MO, Koch C, et al. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 1996; 70 : 5935-43.
5. Duliege A-M, Sinangil F, Walker C, et al. Recombinant HIV subunit vaccines development: a collaborative effort, [abstract We.B.3376]. Vancouver, Canada: XI International Conference on AIDS, 1996.
6. Ferrari G, Humphrey W, McElrath, MJ, et al. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc Natl Acad Sci USA 1997; 94 : 1396-401.
7. Fleury B, Janvier G, Pialoux G, et al. Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp 160. J Infect Dis 1996; 174 : 734-8.
8. Girard M, Meignier B, Barre-Sinoussi F, et al. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. J Virol 1995; 69 : 6239-48.
9. Girard M, Yue L, Barre-Sinoussi F, et al. Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain. J Virol 1996; 70 : 8229-33.
10. Graham BS, Keefer MC, McElrath, et al. Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120 - a randomized, double-blind trial. Ann Intern Med 1996; 125 : 270-9.
11. Kostrikis LG, Cao Y, Ngai H, Moore JP, Ho DD. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J Virol 1996; 70 : 445-58.
12. Leitner T. Genetic subtypes of HIV-1. In: Myers G, ed. Human retroviruses and AIDS 1996: a compilation and analysis of nucleic acid and amino acid sequences Los Alamos, NM: Los Alamos National Laboratory, 1996; III: 28-40.
13. Louwagie J, Janssens W, Mascola J, et al. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1995; 69 : 263-71.
14. Mascola JR, Louder MK, Surman SR, et al. Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay. AIDS Res Hum Retrovir 1996; 12 : 1319-28.
15. Mascola JR, Louwagie J, McCutchan FE, et al. Two antigenically distinct subtypes of human immunodeficiency virus type 1 : viral genotype predicts neutralization serotype. J Infect Dis 1994; 169 : 48-54.
16. McCutchan FE, Artenstein AW, Sanders-Buell E, et al. Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa. J Virol 1996; 70 : 3331-8.
17. McCutchan FE, Hegerich PA, Brennan TP, et al Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retrovir 1992; 8 : 1887-95.
18. Menu E, Lien TTX, Lafon M-E, et al. HIV type 1 Thai subtype E is predominant in South Vietnam. AIDS Res Hum Retrovir 1996; 12 : 629-33.
19. Nerurkar VR, Nguyen HT, Dashwood W-M, et al. HIV type 1 subtype E in commercial sex workers and injection drug users in southern Vietnam. AIDS Res Hum Retrovir 1996; 12 : 841-3.
20. Ou C-Y, Takebe Y, Weniger BG, et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 1993; 341 : 1171-4.
21. Perkins ME, Tartaglia J, Paoletti E. Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases. J Leukocyte Biol 1995; 58 : 1-13.
22. Plotkin SA, Cadoz M, Meignier B, et al. The safety and use of canarypox vectored vaccines. Dev Biol Stand 1995; 84 : 165-70.
23. Porter KR, Mascola JR, Hupudio H, et al. Genetic, antigenic and serologic characterization of human immunodeficiency virus type 1 from Indonesia. J Acquir Immune Defic Syndr 1997; 14 : 1-6.
24. Soeprapto W, Ertono S, Hudoyo H, et al. HIV and peacekeeping operations in Cambodia. Lancet 1995; 346 : 1304-5.
25. Takebe Y, Kusagawa S, Sato H, et al. Molecular epidemiology of HIV-1 spread in Southeast Asia, [abstract Tu.C 221]. Vancouver, Canada: XI International Conference on AIDS, 1996.
26. Wasi C, Herring B, Raktham S, et al. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E. AIDS 1995; 9 : 843-9.
27. Weniger BG, Takebe Y, Ou C-Y, Yamazaki S. The molecular epidemiology of HIV in Asia. AIDS 1994; 8(suppl 2): S13-28.
28. World Health Organization. Acquired immunodeficiency syndrome (AIDS) - Data as of 20 November 1996. WHO Weekly Epidemiol Rec 1996; 48 : 361-4.
29. Yu X-F, Wang Z, Beyrer C, et al. Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand. J Virol 1995; 69 : 4649-55.
30. Zolla-Pazner S, Alving C, Belshe R, et al. Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines. J Infect Dis 1997; 175 : 764-74.